Virtus ETF Advisers’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15,039
| Closed | -$141K | – | 487 |
|
|
2022
Q1 | $141K | Sell |
15,039
-893
| -6% | -$8.37K | 0.06% | 235 |
|
|
2021
Q4 | $189K | Buy |
15,932
+4,597
| +41% | +$54.5K | 0.07% | 233 |
|
|
2021
Q3 | $129K | Sell |
11,335
-595
| -5% | -$6.77K | 0.06% | 366 |
|
|
2021
Q2 | $214K | Sell |
11,930
-10,982
| -48% | -$197K | 0.09% | 296 |
|
|
2021
Q1 | $355K | Buy |
22,912
+409
| +2% | +$6.34K | 0.15% | 207 |
|
|
2020
Q4 | $275K | Sell |
22,503
-9,734
| -30% | -$119K | 0.11% | 265 |
|
|
2020
Q3 | $414K | Sell |
32,237
-4,403
| -12% | -$56.5K | 0.22% | 163 |
|
|
2020
Q2 | $372K | Buy |
+36,640
| New | +$372K | 0.18% | 230 |
|
|
2018
Q4 | – | Sell |
-15,992
| Closed | -$640K | – | 394 |
|
|
2018
Q3 | $640K | Sell |
15,992
-11,506
| -42% | -$460K | 0.07% | 86 |
|
|
2018
Q2 | $778K | Buy |
27,498
+7,401
| +37% | +$209K | 0.69% | 45 |
|
|
2018
Q1 | $307K | Buy |
20,097
+10,646
| +113% | +$163K | 0.27% | 115 |
|
|
2017
Q4 | $308K | Buy |
+9,451
| New | +$308K | 0.39% | 119 |
|